Ontology highlight
ABSTRACT: Importance
Frequent aspirin use is associated with reduced ovarian cancer risk, but it is unknown whether genetic factors modify this association. Understanding effect modifiers is important given that any use of aspirin for ovarian cancer chemoprevention will likely need to focus on specific higher-risk subgroups.Objective
To evaluate whether the association between frequent aspirin use and ovarian cancer is modified by a polygenic score (PGS) for nonmucinous ovarian cancer.Design, setting, and participants
We pooled individual-level data from 8 population-based case-control studies from the Ovarian Cancer Association Consortium conducted in the US, UK, and Australia between 1995 and 2009. We included case patients and control participants with both genetic data an
SUBMITTER: Hurwitz LM
PROVIDER: S-EPMC9958519 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature